🇺🇸 FDA
Company

Shuttle

Shuttle Pharmaceuticals Holdings

SHPH pharma USA

Quick answer

Shuttle is a pharma company (SHPH) headquartered in GAITHERSBURG, MD, USA with 1 tracked pipeline programs.

Pipeline (1)

project

Ropidoxuridine

Glioblastoma, IDH-wildtype

Phase 2 · small_molecule · terminated

1 trials

Patents (8)

patent

US 12357650

Methods and compositions for cancer therapies that include delivery of halogenat

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12077515

Selective histone deacetylase inhibitors for the treatment of human disease

Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11654157

Methods and compositions for cancer therapies that include delivery of halogenat

Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11584733

Selective histone deacetylase inhibitors for the treatment of human disease

Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11407723

Selective histone deacetylase inhibitors for the treatment of human disease

Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11034667

Selective histone deacetylase inhibitors for the treatment of human disease

Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10745352

Dual function molecules for histone deacetylase inhibition and ataxia telangiect

Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10730834

Dual function molecules for histone deacetylase inhibition and ataxia telangiect

Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)